Prakash Radhakrishnan

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Topics

Structural Basis

Liver Metastases

Signaling Pathway

Monoclonal Antibody

Top Venues

Molecular cancer therapeutics

Proceedings of the National Academy of Sciences of the United States of America

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Eric N Aguilar, Satish Sagar, Brandy R Murray, Christabelle Rajesh, Eric K Lei, Sarah A Michaud, David R Goodlett, Thomas C Caffrey, Paul M Grandgenett, Benjamin Swanson, Teresa M Brooks, Adrian R Black, Henk van Faassen, Greg Hussack, Kevin A Henry, Michael A Hollingsworth, Cory L Brooks, Prakash Radhakrishnan
Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6. Molecular cancer therapeutics (2024)
Eric N Aguilar, Satish Sagar, Brandy R Murray, Christabelle Rajesh, Eric K Lei, Sarah A Michaud, David R Goodlett, Thomas C Caffrey, Paul M Grandgenett, Benjamin Swanson, Teresa M Brooks, Adrian R Black, Henk van Faassen, Greg Hussack, Kevin A Henry, Michael A Hollingsworth, Cory L Brooks, Prakash Radhakrishnan
Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6. Molecular cancer therapeutics (2024)
Khadija Turabi, Kelsey Klute, Prakash Radhakrishnan
Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies. Cancers 16 (13) (2024)
Eric N Aguilar, Satish Sagar, Brandy R Murray, Christabelle Rajesh, Eric K Lei, Sarah A Michaud, David R Goodlett, Thomas C Caffrey, Paul M Grandgenett, Benjamin Swanson, Teresa M Brooks, Adrian R Black, Henk van Faassen, Greg Hussack, Kevin A Henry, Michael A Hollingsworth, Cory L Brooks, Prakash Radhakrishnan
Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6. Molecular cancer therapeutics 23 (6) (2024)
Khadija Turabi, Kelsey Klute, Prakash Radhakrishnan
Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies. Cancers 16 (13) (2024)
Eric N Aguilar, Satish Sagar, Brandy R Murray, Christabelle Rajesh, Eric K Lei, Sarah A Michaud, David R Goodlett, Thomas C Caffrey, Paul M Grandgenett, Benjamin Swanson, Teresa M Brooks, Adrian R Black, Henk van Faassen, Greg Hussack, Kevin A Henry, Michael A Hollingsworth, Cory L Brooks, Prakash Radhakrishnan
Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6. Molecular cancer therapeutics 23 (6) (2024)
Eric N Aguilar, Satish Sagar, Brandy R Murray, Christabelle Rajesh, Eric K Lei, Sarah A Michaud, David R Goodlett, Thomas C Caffrey, Paul M Grandgenett, Benjamin Swanson, Teresa M Brooks, Adrian R Black, Henk van Faassen, Greg Hussack, Kevin A Henry, Michael A Hollingsworth, Cory L Brooks, Prakash Radhakrishnan
Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6. Molecular cancer therapeutics 23 (6) (2024)
Eric N Aguilar, Satish Sagar, Brandy R Murray, Christabelle Rajesh, Eric K Lei, Sarah A Michaud, David R Goodlett, Thomas C Caffrey, Paul M Grandgenett, Benjamin Swanson, Teresa M Brooks, Adrian R Black, Henk van Faassen, Greg Hussack, Kevin A Henry, Michael A Hollingsworth, Cory L Brooks, Prakash Radhakrishnan
Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6. Molecular cancer therapeutics 23 (6) (2024)
Sai Kiran Sharma, Kyeara N Mack, Alessandra Piersigilli, Jacob Pourat, Kimberly J Edwards, Outi Keinänen, Maria S Jiao, Huiyong Zhao, Brandy White, Cory L Brooks, Elisa De Stanchina, Madi R Madiyalakan, Michael A Hollingsworth, Prakash Radhakrishnan, Jason S Lewis, Brian M Zeglis
ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (5) (2022)
Christabelle Rajesh, Satish Sagar, Ashok Kumar Rathinavel, Divya Thomas Chemparathy, Xianlu Laura Peng, Jen Jen Yeh, Michael A Hollingsworth, Prakash Radhakrishnan
Truncated O-Glycan-Bearing MUC16 Enhances Pancreatic Cancer Cells Aggressiveness via α4β1 Integrin Complexes and FAK Signaling. International journal of molecular sciences 23 (10) (2022)
John Victor Napoleon, Satish Sagar, Sydney P Kubica, Lidia Boghean, Smit Kour, Hannah M King, Yogesh A Sonawane, Ayrianne J Crawford, Nagsen Gautam, Smitha Kizhake, Pawel A Bialk, Eric Kmiec, Jayapal Reddy Mallareddy, Prathamesh P Patil, Sandeep Rana, Sarbjit Singh, Janani Prahlad, Paul M Grandgenett, Gloria E O Borgstahl, Gargi Ghosal, Yazen Alnouti, Michael A Hollingsworth, Prakash Radhakrishnan, Amarnath Natarajan
Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growth. Proceedings of the National Academy of Sciences of the United States of America 119 (18) (2022)
Satish Sagar, Ashok Kumar Rathinavel, William E Lutz, Lucas R Struble, Surender Khurana, Andy T Schnaubelt, Nitish Kumar Mishra, Chittibabu Guda, Nicholas Y Palermo, Mara J Broadhurst, Tobias Hoffmann, Kenneth W Bayles, St Patrick M Reid, Gloria E O Borgstahl, Prakash Radhakrishnan
Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike protein. Clinical and translational medicine 11 (2) (2021)
Spas Dimitrov Markov, Thomas C Caffrey, Kelly A O'Connell, James A Grunkemeyer, Simon Shin, Ryan Hanson, Prathamesh P Patil, Surendra K Shukla, Daisy Gonzalez, Ayrianne J Crawford, Krysten E Vance, Ying Huang, Kirsten C Eberle, Prakash Radhakrishnan, Paul M Grandgenett, Pankaj K Singh, Ragupathy Madiyalakan, Tracy R Daniels-Wells, Manuel L Penichet, Christopher F Nicodemus, Jill A Poole, Elizabeth D Thompson, Michael A Hollingsworth, Kamiya Mehla
IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer. Molecular cancer therapeutics 20 (12) (2021)
Priyanka Swami, Kelly A O'Connell, Swetha Thiyagarajan, Ayrianne Crawford, Prathamesh Patil, Prakash Radhakrishnan, Simon Shin, Thomas C Caffrey, James Grunkemeyer, Tammi L Neville, Stefan W Vetter, Michael A Hollingsworth, Estelle Leclerc
Inhibition of the Receptor for Advanced Glycation End Products Enhances the Cytotoxic Effect of Gemcitabine in Murine Pancreatic Tumors. Biomolecules 11 (4) (2021)
Madeline T Olson, Nicholas E Wojtynek, Geoffrey A Talmon, Thomas C Caffrey, Prakash Radhakrishnan, Quan P Ly, Michael A Hollingsworth, Aaron M Mohs
Development of a MUC16-Targeted Near-Infrared Fluorescent Antibody Conjugate for Intraoperative Imaging of Pancreatic Cancer. Molecular cancer therapeutics 19 (8) (2020)
Divya Thomas, Prakash Radhakrishnan
Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis. Molecular cancer 18 (1) (2019)
Divya Thomas, Satish Sagar, Thomas Caffrey, Paul M Grandgenett, Prakash Radhakrishnan
Truncated O-glycans promote epithelial-to-mesenchymal transition and stemness properties of pancreatic cancer cells. Journal of cellular and molecular medicine 23 (10) (2019)
Premila Devi Leiphrakpam, Prathamesh P Patil, Neeley Remmers, Benjamin Swanson, Paul M Grandgenett, Fang Qiu, Fang Yu, Prakash Radhakrishnan
Role of keratan sulfate expression in human pancreatic cancer malignancy. Scientific reports 9 (1) (2019)